Deka Bank Deutsche Girozentrale Regeneron Pharmaceuticals, Inc. Transaction History

Deka Bank Deutsche Girozentrale

$55.6 Billion
Q2 2024

A detailed history of Deka Bank Deutsche Girozentrale transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Deka Bank Deutsche Girozentrale holds 213,824 shares of REGN stock, worth $223 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares

213,824

Previous 221,176 3.32%

Holding current value

$223 Million

Previous $213 Million 5.26%

% of portfolio

0.4%

Previous 0.4%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$883.2 - $1071.19 $6.49 Million - $7.88 Million	-7,352 Reduced 3.32%	213,824 $224 Million
Q1 2024 Apr 24, 2024	SELL	$902.69 - $993.35 $2.72 Million - $2.99 Million	-3,009 Reduced 1.34%	221,176 $213 Million
Q4 2023 Jan 24, 2024	BUY	$775.18 - $881.7 $18.4 Million - $21 Million	23,795 Added 11.87%	224,185 $196 Million
Q3 2023 Nov 13, 2023	BUY	$692.45 - $844.37 $22.5 Million - $27.5 Million	32,538 Added 19.38%	200,390 $167 Million
Q2 2023 Jul 25, 2023	SELL	$700.03 - $830.35 $4.09 Million - $4.85 Million	-5,839 Reduced 3.36%	167,852 $119 Million
Q1 2023 Apr 24, 2023	BUY	$680.49 - $826.97 $1.84 Million - $2.23 Million	2,702 Added 1.58%	173,691 $140 Million
Q4 2022 Feb 01, 2023	SELL	$705.89 - $766.39 $5.56 Million - $6.04 Million	-7,881 Reduced 4.41%	170,989 $122 Million
Q3 2022 Nov 02, 2022	BUY	$573.97 - $724.32 $4.39 Million - $5.55 Million	7,656 Added 4.47%	178,870 $123 Million
Q2 2022 Aug 03, 2022	BUY	$548.35 - $738.84 $11.1 Million - $14.9 Million	20,227 Added 13.4%	171,214 $102 Million
Q1 2022 Apr 28, 2022	BUY	$595.12 - $698.43 $27 Million - $31.7 Million	45,440 Added 43.05%	150,987 $106 Million
Q4 2021 Feb 02, 2022	BUY	$543.48 - $670.97 $4.91 Million - $6.06 Million	9,029 Added 9.35%	105,547 $68.2 Million
Q3 2021 Oct 22, 2021	BUY	$574.03 - $680.96 $7.34 Million - $8.71 Million	12,787 Added 15.27%	96,518 $59.1 Million
Q2 2021 Aug 05, 2021	BUY	$472.8 - $558.54 $2.28 Million - $2.69 Million	4,819 Added 6.11%	83,731 $45.7 Million
Q1 2021 Apr 28, 2021	BUY	$446.73 - $548.2 $8.32 Million - $10.2 Million	18,627 Added 30.9%	78,912 $37.1 Million
Q4 2020 Mar 12, 2021	BUY	$478.3 - $607.98 $5.22 Million - $6.63 Million	10,908 Added 22.09%	60,285 $29.3 Million
Q3 2020 Oct 29, 2020	BUY	$544.75 - $658.21 $19.8 Million - $23.9 Million	36,266 Added 276.61%	49,377 $29.3 Million
Q2 2020 Aug 04, 2020	BUY	$493.32 - $643.92 $774,512 - $1.01 Million	1,570 Added 13.6%	13,111 $8.03 Million
Q1 2020 May 14, 2020	BUY	$336.18 - $494.43 $14,791 - $21,754	44 Added 0.38%	11,541 $5.56 Million
Q4 2019 Feb 04, 2020	SELL	$274.13 - $376.51 $10.3 Million - $14.1 Million	-37,530 Reduced 76.55%	11,497 $4.27 Million
Q3 2019 Nov 14, 2019	SELL	$273.46 - $318.39 $2.91 Million - $3.39 Million	-10,645 Reduced 17.84%	49,027 $13.5 Million
Q2 2019 Aug 01, 2019	BUY	$299.6 - $414.82 $3.74 Million - $5.18 Million	12,494 Added 26.48%	59,672 $18.6 Million
Q1 2019 May 10, 2019	BUY	$372.08 - $439.57 $3.05 Million - $3.6 Million	8,195 Added 21.02%	47,178 $19.4 Million
Q4 2018 Feb 12, 2019	SELL	$335.82 - $403.04 $2.75 Million - $3.3 Million	-8,195 Reduced 17.37%	38,983 $14.3 Million
Q3 2018 Nov 09, 2018	SELL	$351.14 - $408.51 $5.25 Million - $6.11 Million	-14,951 Reduced 24.06%	47,178 $0
Q2 2018 Aug 14, 2018	BUY	$284.6 - $344.99 $4.27 Million - $5.17 Million	14,995 Added 31.81%	62,129 $21.3 Million
Q1 2018 May 03, 2018	SELL	$315.82 - $393.78 $7.4 Million - $9.23 Million	-23,435 Reduced 33.21%	47,134 $16.1 Million
Q4 2017 Feb 14, 2018	BUY	$358.63 - $469.95 $161,383 - $211,477	450 Added 0.64%	70,569 $33.2 Million
Q3 2017 Nov 06, 2017	BUY	$431.38 - $504.0 $30.2 Million - $35.3 Million	70,119	70,119 $33 Million

Others Institutions Holding REGN

# of Institutions

1,463

Shares Held

84.5M

Call Options Held

907K

Put Options Held

1.3M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $112B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.

Account

Deka Bank Deutsche Girozentrale Regeneron Pharmaceuticals, Inc. Transaction History